Company: CDLX
Filing Date: 2025-04-03
Form Type: DEF 14A
Source: 0001666071-25-000046
Chunk: 89

Company: Cardlytics, Inc.
Filing Date: 2025-04-03
Form: DEF 14A
Chunk 89
---
     |            |      | *     |
| Karim Temsamani(8)                                                   |     |                      |   385,530 |     |            |      | *     |
| All current executive officers and directors as a group (10 persons) |     |                      | 2,088,017 |     |            |      | 4.4%* |
| * Represents beneficial ownership of less than 1.0%                  |     |                      |           |     |            |      |       |

(1) Consists of 3,425,295 shares of common stock held by Sosin Master, L.P. and 2,189,483 shares of common stock owned by CSWR Partners, L.P. This information has been obtained from a Schedule 13G/A filed on March 26, 2025 by CAS Investment Partners, LLC., Sosin Master, LP, CSWR Partners, LP and Clifford Sosin. Clifford Sosin is the managing member of CAS Investment Partners, LLC, which is the investment manager of Sosin Master, L.P. and CSWR Partners, L.P. By virtue of the foregoing relationships, each of the reporting persons may be deemed to beneficially own the securities held by Sosin Master, L.P. and CSWR Partners, L.P. The address of CAS Investment Partners, LLC is 575 Lexington Avenue, Suite 12-101, New York, NY 10022.

(2) This information has been obtained from a Schedule 13G/A filed on November 12, 2024 by entities associated with BlackRock, Inc. The address for BlackRock, Inc. is 50 Hudson Yards, New York, NY 10001.

(3) Includes 43,750 shares of common stock issuable upon the settlement of restricted stock unit awards within 60 days of March 26, 2025.

(4) Includes 43,750 shares of common stock issuable upon the settlement of restricted stock unit awards within 60 days of March 26, 2025.

(5) Includes (i) 582 shares of common stock issuable upon the settlement of restricted stock unit awards within 60 days of March 26, 2025, (ii) 1,578 shares of common stock issuable upon the exercise of options that are exercisable within 60 days of March 26, 2025 and (iii) 10,630 shares of common stock iss